Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
37699-43-7Cc1c([N+](=O)[O-])cc[n+]([O-])c1CCFMTVTYBZMKULI-UHFFFAOYSA-N37699-43-7DTXSID50191134Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (14%): Harmful if swallowed [Warning Acute toxicity, oral]
P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 50 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Status: Active Update: 11-03-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/33360
Pyridine, 2,3-dimethyl-4-nitro-, 1-oxide: Does not have an individual approval but may be used under an appropriate group standard
VerwendenNitropyridine oxide derivative,Nitropyridine oxide derivatives show carcinogenicity and mutagenicity.
Wird geladen…